Загрузка...
The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis
Neurodegenerative movement disorders mainly include Parkinson’s disease, atypical parkinsonisms, Huntington disease, and hereditary ataxia. Riluzole is the only drug approved by the US Food and Drug Administration for amyotrophic lateral sclerosis. The neuroprotective effects of riluzole have been o...
Сохранить в:
| Опубликовано в: : | Drug Deliv |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058579/ https://ncbi.nlm.nih.gov/pubmed/29226728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1413446 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|